The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The next generation sequencing (NGS) market has witnessed a remarkable surge in recent years, with its size escalating from $10.44 billion in 2023 to $11.83 billion in 2024, marking a significant compound annual growth rate (CAGR) of 13.3%. Several factors have propelled this growth:

1. Increased Healthcare Expenditure
2. Rapid Technological Advances
3. Emerging Markets Growth
4. Rise in Funding
5. Growing Elderly Population

Charting the Future

Looking ahead, the growth trajectory appears even more promising. By 2028, the market is projected to soar to $19.75 billion, exhibiting a CAGR of 13.7%. Key drivers of this forecasted expansion include:

1. Aging Population
2. Enhanced Healthcare Access
3. Surging Prevalence of Chronic Diseases
4. Rising Demand Due to COVID-19

Embracing Transformative Trends

In the upcoming years, the NGS market is poised to witness transformative trends that will reshape its landscape:

1. Integration of Artificial Intelligence
2. Cost-Effective Study of Rare Diseases
3. Expansion into Newborn Screening
4. Utilization of Big Data Technologies

View More On The Next Generation Sequencing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

Rising Incidence Of Chronic Diseases Drives Growth In The Next-Generation Sequencing Market

The Chronic Disease Conundrum

The prevalence of chronic diseases such as cancer, AIDS, and thalassemia has surged globally, fueling the demand for next-generation sequencing. Factors contributing to this rise include:

1. Aging Population
2. Shifts in Social Behavior

NGS: A Versatile Tool

Next-generation sequencing serves as a versatile tool for researchers and clinicians, aiding in the identification of biomarkers crucial for treatment decisions, especially in cancer studies.

Market Leaders

Major players dominating the NGS market include Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, and others, contributing significantly to market growth.

Innovative Technologies Driving Growth In The Next Generation Sequencing Market

Pioneering Innovations

Leading companies are spearheading innovations such as the AVENIO Edge System, aimed at enhancing profitability and efficiency in the market.

The AVENIO Edge System

This automated system streamlines sample preparation, target enrichment, and data processing, offering high-quality sequencing results with minimal hands-on time.

Market Segmentation

Product Segmentation

The NGS market encompasses instruments, reagents and kits, and software, catering to diverse needs within the industry.

Technology Segmentation

Technological advancements have led to the emergence of various sequencing methods, including sequencing by synthesis, ion semiconductor sequencing, and nanopore sequencing, among others.

Application Segmentation

NGS finds applications in diagnostics, drug discovery, and other sectors, reflecting its versatility and relevance across multiple domains.

Regional Insights

North America Dominance

In 2023, North America emerged as the largest region in the NGS market, underscoring the region’s pivotal role in driving market growth.

In conclusion, the next-generation sequencing market is on an upward trajectory, fueled by technological innovations, rising healthcare needs, and the imperative for precision medicine. With transformative trends and pioneering technologies, the future of NGS holds immense promise in revolutionizing healthcare delivery and research worldwide.

Request A Sample Of The Global Next Generation Sequencing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3990&type=smp